Optimal regimen of cisplatin in squamous cell carcinoma of head ...

Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial.

Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined.

Optimal regimen of cisplatin in squamous cell carcinoma of head ...

Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. Xiuning Le, Ehab Y. Hanna. Abstract. Head and neck cancers ...

Optimal Dose of Cisplatin (CDDP) Given Concurrently with ...

Locally advanced squamous cell head and neck cancer. (SQC HNC) represent a significant therapeutic chal- lenge for head and neck oncologists. While all three.

Optimal cumulative cisplatin dose for radio-sensitization in locally ...

Conclusions: This study confirms that a cumulative cisplatin dose of ~ 210 mg/m2 is optimum for increasing PFS in patients with head and neck ...

Concurrent chemoradiotherapy with cisplatin given once-a-week ...

National Comprehensive Cancer Network (NCCN) guidelines version 2.2022 for head and neck cancers [19] recommends high-dose three-weekly cisplatin as the ...

Once-a-Week Versus Once-Every-3-Weeks Cisplatin ...

In locally advanced head and neck squamous cell carcinoma (LAHNSCC), high-dose (100 mg/m2) once-every-3-weeks cisplatin added to curative ...

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent ...

Concurrent chemoradiotherapy is an established component of the nonoperative management of locally advanced head and neck squamous cell ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

The number of older adults with head and neck squamous cell carcinoma (HNSCC) is increasing, and treatment of these patients is challenging.

Optimal regimen of cisplatin in squamous cell carcinoma of head ...

The most common types of head and neck cancers can arise in the oral cavity, pharynx, larynX, nasal cavity, paranasal sinuses, thyroid, and salivary glands ...

292-Head and neck SCC locally advanced definitive ciSplatin ... - eviQ

Standard treatment for locally advanced (stage III-IV) head and neck squamous cell cancer (LA-HNSCC) is concurrent chemoradiation therapy (CCRT) with cisplatin ...

Treating Patients With Locally Advanced Squamous Cell Carcinoma ...

Concurrent chemoradiotherapy with high-dose cisplatin (100 mg/m 2 every 3 weeks) is the preferred regimen with curative intent for patients with unresected ...

Three Weekly Versus Weekly Cisplatin: Comparison of two Different ...

Introduction: Chemoradiotherapy (CRT) with concurrent cisplatin-based chemotherapy is the treatment of choice of locally advanced head and neck ...

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell ...

Cisplatin is the standard for the chemoradiation of squamous cell carcinoma of the head and neck (HNSCC). Many patients cannot receive cisplatin due to ...

Survival and toxicity of weekly cisplatin chemoradiotherapy versus ...

The optimal cisplatin-based regimen in head and neck cancer is still debated. · Three-weekly cisplatin chemoradiotherapy is considered the standard treatment.

Radical radiotherapy with concurrent weekly cisplatin in loco ...

Outcome data of patients with Stage III & IV head and neck squamous cell carcinoma, excluding nasopharynx, planned for radical radiotherapy (66– ...

Cisplatin Eligibility Issues and Alternative Regimens in ... - Frontiers

In chemoradiotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN), data support the use of three cycles of 100 mg/m2 cisplatin given ...

Chemotherapy of head and neck cancer - Annals of Oncology

Cisplatin is probably the most widely used agent to treat squamous cell carcinoma of the head and neck. Its efficacy is well established for the palliation of ...

Optimal regimen of cisplatin in squamous cell carcinoma of head ...

Head and neck cancers account for more than 550000 cases and 380000 deaths annually worldwide and are the 6 th most common cancer type (1).

Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in ...

Locally advanced head and neck squamous cell carcinoma (HNSCC) is currently treated with concurrent chemoradiation (CRT) or surgery followed by ...